Tezepelumab Reduces Alarmin Cytokine Levels in Upper Airway Epithelial Cells in Patients With Severe Asthma
Summary Nasal epithelial cell alarmin cytokine levels are reduced in patients with severe asthma following tezepelumab. This is the first report showing nasal alarmin cytokine protein expression depletion following biologics.
Authors
- Adil Adatia (ORCID: https://orcid.org/0000-0002-7612-6529)
- Hazel Marriott (ORCID: https://orcid.org/0000-0002-5742-0028)
- Paige Lacy
- Subhabrata Moitra
Institutions
- Gujarat University (IN)
- University of Alberta (CA)
- Ahmedabad University (IN)
Publication Details
- Journal
- Clinical & Experimental Allergy
- Published
- 2026-03-27
- DOI
- https://doi.org/10.1111/cea.70294
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00